 Disease Management
"Disease Management" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)
| Descriptor ID |
D019468
|
| MeSH Number(s) |
N04.590.607
|
| Concept/Terms |
Disease Management- Disease Management
- Disease Managements
- Management, Disease
- Managements, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Management".
Below are MeSH descriptors whose meaning is more specific than "Disease Management".
This graph shows the total number of publications written about "Disease Management" by people in this website by year, and whether "Disease Management" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 2 | 1 | 3 | | 2000 | 0 | 1 | 1 | | 2001 | 1 | 2 | 3 | | 2002 | 2 | 1 | 3 | | 2003 | 1 | 2 | 3 | | 2004 | 1 | 1 | 2 | | 2005 | 3 | 5 | 8 | | 2006 | 2 | 4 | 6 | | 2007 | 3 | 2 | 5 | | 2008 | 2 | 3 | 5 | | 2009 | 0 | 2 | 2 | | 2010 | 1 | 4 | 5 | | 2011 | 4 | 16 | 20 | | 2012 | 7 | 8 | 15 | | 2013 | 8 | 8 | 16 | | 2014 | 9 | 11 | 20 | | 2015 | 18 | 24 | 42 | | 2016 | 11 | 36 | 47 | | 2017 | 15 | 35 | 50 | | 2018 | 14 | 28 | 42 | | 2019 | 13 | 38 | 51 | | 2020 | 8 | 25 | 33 | | 2021 | 5 | 20 | 25 | | 2022 | 0 | 4 | 4 | | 2023 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Disease Management" by people in Profiles.
-
Alvarez E, Longbrake EE, Rammohan KW, Stankiewicz J, Hersh CM. Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management. Mult Scler Relat Disord. 2023 Nov; 79:105009.
-
Leung HMC, Forlenza GP, Prioleau TO, Zhou X. Noninvasive Glucose Sensing In Vivo. Sensors (Basel). 2023 Aug 09; 23(16).
-
Del Rivero J, Mailman J, Rabow MW, Chan JA, Creed S, Kennecke HF, Pasieka J, Zuar J, Singh S, Fishbein L. Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care. Endocr Relat Cancer. 2023 07 01; 30(7).
-
Koskela-Staples NC, Evans C, Turner EM, Black LV, Fedele DA. The Association Between Caregiver Coping and Youth Clinic Attendance and Health-related Quality of Life in Pediatric Sickle Cell Disease. J Pediatr Hematol Oncol. 2023 05 01; 45(4):e433-e440.
-
Venechuk G, Allen LA, Thompson JS, Morris MA, Matlock DD, McIlvennan CK, Dickert NW, Tietbohl C. Trust and activation in defining patient-clinician interactions for chronic disease management. Patient Educ Couns. 2023 Jan; 106:113-119.
-
Morrow CD, Perraillon MC, Wald HL, Nelson JL, Reeder BP, Battaglia C, Boxer RS. Challenges in Heart Failure Disease Management in Skilled Nursing Facilities: A Qualitative Study. J Gerontol Nurs. 2022 May; 48(5):14-17.
-
DeVine MN, Maxwell S, Haynes AS, MacBrayne CE, Boguniewicz J. Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e293-e295.
-
Varty M, Speller-Brown B, Wakefield BJ, Ravert RD, Kelly KP, Popejoy LL. Decision-Making Involvement, Self-Efficacy, and Transition Readiness in Youth With Sickle Cell Disease. Nurs Res. 2022 Jan-Feb 01; 71(1):12-20.
-
Sabaawy HE, Ryan BM, Khiabanian H, Pine SR. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance. Carcinogenesis. 2021 12 31; 42(12):1411-1419.
-
Roeker LE, Eyre TA, Thompson MC, Lamanna N, Coltoff AR, Davids MS, Baker PO, Leslie L, Rogers KA, Allan JN, Cordoba R, Lopez-Garcia A, Antic D, Pagel JM, Martinez-Calle N, Garc?a-Marco JA, Hern?ndez-Rivas J?, Miras F, Coombs CC, ?sterborg A, Hansson L, Seddon AN, L?pez Jim?nez J, Wilson MR, El-Sharkawi D, Wojenski D, Ma S, Munir T, Valenciano S, Seymour E, Barr PM, Pu J, Patten PEM, Perini GF, Huntington SF, Parry H, Sundaram S, Skarbnik A, Kamdar M, Jacobs R, Walter H, Walewska R, Broom A, Lebowitz S, Isaac KM, Portell CA, Ahn IE, Ujjani CS, Shadman M, Sk?nland SS, Chong EA, Mato AR. COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood. 2021 11 04; 138(18):1768-1773.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|